Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ciba-Geigy Moscow purchases SeroStrip tests:

This article was originally published in Clinica

Executive Summary

Swiss company Ciba-Geigy's Moscow representative has purchased 3,000 SeroStrip HIV-1/2 tests from Saliva Diagnostic Systems (US). SDS says that the Russian military has also expressed interest in the test. SeroStrip received approval for use and sale within Russia in January this year. Clinical trial evaluation for HemaStrip HIV-1/2, SDS' rapid antibody test, has been completed in Russia and the company expects the product to be registered there shortly.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT088201

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel